We compared the safety and efficacy of haploidentical stem cell transplantation (haplo-SCT)
to matched donor SCT (matched-SCT) in treating hematological malignancies. The Medline …

Background Human leukocyte antigen‐identical sibling donor (ISD)‐hematopoietic stem cell
transplantation (SCT) is a potentially curative treatment for high‐risk pediatric acute myeloid …

In patients with acute myeloid leukemia (AML) of intermediate-risk (IR) in first remission
(CR1) with no measurable residual disease (MRD negative), the choice of the best …

The efficacy of donor lymphocyte infusion (DLI) without chemotherapy was investigated and
compared with that of chemotherapy prior to DLI (Chemo-DLI) in patients who were minimal …

Allogenic hematopoietic cell transplantation (HSCT) is typically the preferred curative
therapy for adult patients with acute myeloid leukemia, but its use has been reduced as a …

Purpose: Graft-versus-host disease (GVHD) is an important complication after human
leukocyte antigen (HLA) haploidentical donor (HID) hematopoietic stem cell transplantation …

A key issue in the haploiedntical hematopoietic stem cell transplantation (haplo-HSCT)
setting is the search for the best donor, because donor selection can significantly impact the …

Use of high-dose, post-transplant cyclophosphamide (PTCy) results in low rates of graft-
versus-host-disease (GVHD) and favorable immune reconstitution, although with higher …

As a serious complication after allogenic hematopoietic stem cell transplantation (allo-
HSCT), venous thromboembolism (VTE) is significantly related to increased nonrelapse …

“Beijing group” has pioneered a different approach with T-cell replete HID, intensive
myeloablation, a combination of G-CSF-primed bone marrow plus peripheral blood as the …